Optimization of Culture Conditions for the Production of Lovastatin by Aspergillus Terreus in Submerged Fermentation

Exploitation of Sugarcane Bagasse and Environmentally Sustainable Production, Purification, Characterization, and Application of Lovastatin by Aspergillus terreus AUMC 15760 under Solid-State Conditions

Using the internal transcribed spacer (ITS) region for identification, three strains of Aspergillus terreus were identified and designated AUMC 15760, AUMC 15762, and AUMC 15763 for the Assiut University Mycological Centre culture collection. The ability of the three strains to manufacture lovastatin in solid-state fermentation (SSF) using wheat bran was assessed using gas chromatography-mass spectroscopy (GC-MS). The most potent strain was strain AUMC 15760, which was chosen to ferment nine types of lignocellulosic waste (barley bran, bean hay, date palm leaves, flax seeds, orange peels, rice straw, soy bean, sugarcane bagasse, and wheat bran), with sugarcane bagasse turning out to be the best substrate. After 10 days at pH 6.0 at 25 °C using sodium nitrate as the nitrogen source and a moisture content of 70%, the lovastatin output reached its maximum quantity (18.2 mg/g substrate). The medication was produced in lactone form as a white powder in its purest form using column chromatography. In-depth spectroscopy examination, including ¹H, ¹³C-NMR, HR-ESI-MS, optical density, and LC-MS/MS analysis, as well as a comparison of the physical and spectroscopic data with published data, were used to identify the medication. At an IC₅₀ of 69.536 ± 5.73 µM, the purified lovastatin displayed DPPH activity. Staphylococcus aureus and Staphylococcus epidermidis had MICs of 1.25 mg/mL, whereas Candida albicans and Candida glabrata had MICs of 2.5 mg/mL and 5.0 mg/mL, respectively, against pure lovastatin. As a component of sustainable development, this study offers a green (environmentally friendly) method for using sugarcane bagasse waste to produce valuable chemicals and value-added commodities.

Ultrasonic Irradiation Enables Facile Production of Lovastatin from Sugar Cane Bagasse

This study investigated the effect of ultrasound-assisted hydrogen peroxide (H₂O₂) pretreatment on sugar cane bagasse (SCB) followed by Monascus purpureus TISTR 3003 cultivation for lovastatin production under solid-state fermentation (SSF). Optimization of the pretreatment conditions was investigated using a response surface methodology (RSM). Within the range of the selected operating conditions, the optimized values of H₂O₂ concentration, amplitude, SCB dosage, and sonication time were found to be 2.74%, 83.22 μm, 2.84% and 52.29 min, respectively. The R ² value of 0.9749 indicated that the fitted model is in good agreement with the predicted and actual lovastatin production. On the basis of the optimum conditions, the lovastatin production was 2347.10 ± 17.19 μg/g, which is 2.4 times higher than that under untreated conditions. Scanning electron microscopy (SEM) analysis explored the surface structure of the untreated SCB, which showed a compact rigid structure. In contrast, treated SCB had a rough surface structure and cracks as a result of the pretreatment.

Submerged fermentation of Ginkgo biloba seed powder using Eurotium cristatum for the development of ginkgo seeds fermented products

BACKGROUND

Ginkgo biloba seeds are well known for the significant curative effects on relieving cough and asthma. However, the development of products from ginkgo seeds still falls behind at present, resulting in a great waste of ginkgo seeds' resource. In this work, submerged fermentation of ginkgo seed powder using Eurotium cristatum was studied to investigate its feasibility as a new processing method.

RESULTS

To promote the growth of E. cristatum, the optimum fermentation medium was 80.0 g L^-1 of ginkgo seed powder with addition of 5.0 g L^-1 calcium chloride (CaCl₂ ), 4.0 g L^-1 magnesium sulfate (MgSO₄ ), 1.25 g L^-1 zinc sulfate (ZnSO₄ ) and 0.65 g L^-1 iron(II) sulfate (FeSO₄ ). The optimum fermentation conditions were pH 5.8 ± 0.1, inoculum size 5.1 × 10⁶  CFU mL^-1 , liquid medium volume 100 mL in 250-mL Erlenmeyer flask and fermentation 4 days. Through fermentation, the production of lovastatin in fermentation broth could reach up to 32.97 ± 0.17 μg mL^-1 and the total antioxidant capacity was improved by more than two-fold. In addition, 40.15% of the ginkgotoxin in ginkgo seed powder was degraded while the entire degradation of ginkgolic acids was obtained. Moreover, fermented ginkgo seed powder suspension presented pleasant fragrances, and the activities of amylase and protease were enhanced to 11.30 ± 0.10 U mL^-1 and 23.01 ± 0.20 U mL^-1 , respectively.

CONCLUSIONS

Submerged fermentation using E. cristatum could significantly enhance the functional value and safety of ginkgo seed powder, and had great potential to become a novel processing method for the development of ginkgo seeds fermented products. © 2020 Society of Chemical Industry.